Lumira Capital Investment Management Inc.'s Form 4 filing
Edesa Biotech, Inc. (EDSA) · filed Jan 11, 2023
- Accession no.
- 0001213900-23-002248
- Filed
- Jan 11, 2023, 3:42 PM ET
- Trade date
- Jan 9-10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $787.7K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Lumira Capital Investment Management Inc.CIK 0001702636 | 10% Owner |
| van der Velden PeterCIK 0001778046 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 9, 2023 | Common share | SSaleDisposed | −132,845 | $2.66 | −$353,646.67 | 1,764,583 | Indirect | |
| Jan 9, 2023 | Common share | SSaleDisposed | −12,284 | $2.66 | −$32,701.24 | 163,170 | Indirect | |
| Jan 10, 2023 | Common share | SSaleDisposed | −139,450 | $2.63 | −$367,394.97 | 1,625,133 | Indirect | |
| Jan 10, 2023 | Common share | SSaleDisposed | −12,895 | $2.63 | −$33,973.17 | 150,275 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.